Arthritis affects 22.7% of U.S. adults, projected to reach 78.4 million by 2040

An observational analysis examined the prevalence of provider-diagnosed arthritis among U.S. adults. The study did not report the specific sample size, follow-up duration, or detailed methodology for its projections. The population was defined as U.S. adults with a provider diagnosis of arthritis.

The analysis found that an estimated 54.4 million U.S. adults, representing 22.7% of the population, have provider-diagnosed arthritis. It further projected that this number will increase to 78.4 million adults by the year 2040. The study did not report on any specific intervention, exposure, comparator, or primary clinical outcomes related to mental distress or depression management.

Safety and tolerability data were not reported. Key limitations include the lack of reported sample size, methodology details for the 2040 projection, and the absence of data on interventions or comparative effectiveness. The study's relevance to clinical practice is restrained to providing updated epidemiological context on the scale of arthritis in the U.S. population, underscoring the need for healthcare systems to prepare for a larger burden of chronic musculoskeletal disease.